Skip to main content
Category

Insights

CND Life Sciences’ Next Educational Webinar is April 19

By Insights

CND Life Sciences is pleased to announce the next webinar in our Tuesday Night Talks series. Todd Levine, MD, CND’s Co-Founder and Chief Medical Officer
welcomes special guest Stuart H. Isaacson, MD, FAAN, Director of the Parkinson’s Disease and Movement Disorders Center of Boca Raton, FL to discuss the role and importance of alpha-synuclein as a key
pathological marker.

Read More

Rare Disease Day is February 28

By Insights

More than 300 million people, or 5% of the worldwide population, are living with a rare disease, defined as a disease that affects fewer than 200,000 people at any given time. Those with rare diseases are often misdiagnosed or not diagnosed at all, which makes it nearly impossible to find the right care.

Read More

Solving an Unmet Need: A New Diagnostic Paradigm for Neurodegenerative Disorders

By Insights

Arriving at a definitive diagnosis of any given neurodegenerative condition is not always easy. Recent studies have shown that even in the hands of the best movement disorder specialists, patients diagnosed
with Parkinson’s disease who come to autopsy show no evidence of Lewy bodies and have an alternate diagnosis 30% of the time. Similar data exist for patients with multiple sclerosis, Alzheimer’s disease, and immune-mediated neuropathies. These data tell us that clinical diagnostic skills and tests cannot always accurately distinguish the varied forms of neurodegenerative diseases.

Read More